Insider Trading Activity For Aileron Therapeutics Inc (NASDAQ:ALRN)
Rickenbach Josef H Von , Director of Aileron Therapeutics Inc (NASDAQ:ALRN) reportedly Bought 113,145 shares of the company’s stock at an average price of 0.98 for a total transaction amount of $110,882.10 SEC Form
Insider Trading History For Aileron Therapeutics Inc (NASDAQ:ALRN)
On 7/5/2017 Reinhard J Ambros, Director, bought 266,667 with an average share price of $15.00 per share and the total transaction amounting to $4,000,005.00.
On 7/5/2017 Lilly Ventures Fund I Llc, Insider, bought 250,000 with an average share price of $15.00 per share and the total transaction amounting to $3,750,000.00.
On 7/5/2017 Cvf, Llc, Major Shareholder, bought 180,000 with an average share price of $15.00 per share and the total transaction amounting to $2,700,000.00.
On 1/9/2018 Apple Tree Partners Ii Lp, Major Shareholder, sold 150,000 with an average share price of $9.80 per share and the total transaction amounting to $1,470,000.00.
On 4/19/2018 Apple Tree Partners Ii Lp, Major Shareholder, sold 107,904 with an average share price of $6.31 per share and the total transaction amounting to $680,874.24.
On 6/1/2018 Donald Dougherty, CFO, bought 2,000 with an average share price of $5.24 per share and the total transaction amounting to $10,480.00.
On 6/6/2018 Manuel Aivado, Insider, bought 1,000 with an average share price of $5.61 per share and the total transaction amounting to $5,610.00.
Analyst Ratings History For Aileron Therapeutics Inc (NASDAQ:ALRN)
- On 4/9/2019 Canaccord Genuity Lower Price Target of rating Positive to Buy with a price target of $5.00
- On 5/6/2019 William Blair Reiterated Rating Outperform
- On 9/11/2019 HC Wainwright Reiterated Rating Buy with a price target of $6.00
Recent Trading Activity for Aileron Therapeutics Inc (NASDAQ:ALRN)
Shares of Aileron Therapeutics Inc closed the previous trading session at 0.98 up +0.00040 0.041% with 1.05 shares trading hands.